The efficacy of topically applied curcumin 1% as alternative or complementary to triamcinolone acetonate in treatment of oral lichen planus (randomized control trial)

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background

Oral lichen planus (OLP) is a chronic inflammatory disorder affecting the mucous membranes, believed to be an immune-mediated condition. Its persisting nature can lead to extended discomfort for those affected. The primary symptoms are pain and a burning sensation, with a potential risk of malignancy if not properly managed, necessitating lifelong clinical monitoring. Presently, OLP is considered a significant challenge due to the absence of a definitive cure.

Patients and methods

Thirty patients with OLP were divided into three groups, 10 patients each: group A: 10 patients with OLP were received topical triamcinolone acetonide. Group B: 10 patients with OLP were received topical curcumin. Group C: 10 patients with OLP were received topical triamcinolone acetonide combined with topical curcumin for 6 weeks. Each patient was examined at baseline, 1 and 3 months of therapy. Pain was scored using the visual analog scale. Salivary level of interleukin-6 were estimated at baseline, 1 and 3 months evaluation periods.

Results

Significant decrease in pain score was observed in all groups and there was a statistically significant difference between them at all treatment periods in favor to group C. Additionally, all groups showed a decrease in the size of lesions which was greater in group A, C compared to the B group. A significant reduction of the mean interleukin-6 continued down to 3 months in all groups with statistically insignificant difference between them at 3 months, while statistically significant difference in favor to group C at 1 month was observed.

Conclusion

The results proved the benefit of curcumin as a promising medication when used in combination with conventional therapy in treatment of OLP patients. However, further long-term studies with large sample size are needed.

Practical implications

To evaluate the therapeutic impact of topically applied curcumin as alternative or complementary to triamcinolone acetonate in treatment of OLP.

Article activity feed